Company: GANX
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001558370-25-011220
Chunk: 3

Company: Gain Therapeutics, Inc.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part I, Item 1F
Chunk 3
---
Item 1. Condensed Consolidated Financial Statements.

​

PART I—FINANCIAL INFORMATION

​

GAIN THERAPEUTICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

​​​​​​​​ ​        June 30,     December 31, ​​​2025​2024Assets  ​   ​  Current assets:  ​   ​  Cash and cash equivalents ​$ 6,694,136​$ 10,385,863Tax credits​​​ 317,844​​ 271,079Prepaid expenses and other current assets ​  2,294,723​  945,536Total current assets ​​ 9,306,703​​ 11,602,478​​​​​​​​Noncurrent assets: ​   ​   Property and equipment, net ​  96,190​  103,619Internal-use software, net​​​ 127,857​​ 134,268Operating lease right-of-use assets ​  233,200​  219,715Restricted cash ​  36,278​  31,695Long-term deposits and other noncurrent assets ​  33,752​  32,109Total noncurrent assets ​​ 527,277​​ 521,406Total assets ​$ 9,833,980​$ 12,123,884​​​​​​​​Liabilities and stockholders' equity​​​​​​​Current liabilities: ​   ​   Accounts payable ​$ 2,713,013​$ 946,259Operating lease liability - current ​  136,320​  160,913Other current liabilities ​  2,198,918​  2,441,761Deferred grant income - current ​  22,685​  252,211Loans - current ​​ 126,108​​ 110,177Total current liabilities ​​ 5,197,044​​ 3,911,321​​​​​​​​Noncurrent liabilities: ​   ​   Defined benefit pension plan ​​ 522,676​​ 443,623Operating lease liability - noncurrent ​  92,851​  53,598Deferred grant income - noncurrent​​​ —​​ 47,441Loans - noncurrent ​​ 325,359​​